BLUW - Blue Water Acquisition announces business combination with Clarus Therapeutics
Blue Water Acquisition (BLUW -6.8%) approves business combination with Clarus Therapeutics, a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies. Combined company will be named “Clarus Therapeutics Holdings”. Common stock and warrants are expected to start trading on the Nasdaq under the new ticker symbols “CRXT,” and “CRXTW,” respectively.
For further details see:
Blue Water Acquisition announces business combination with Clarus Therapeutics